Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Philip James Wealth Mangement LLC

Philip James Wealth Mangement LLC cut its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 97.1% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 16,782 shares of the pharmacy operator’s stock after selling 565,281 shares during the quarter. Philip James Wealth Mangement LLC’s holdings in Walgreens Boots Alliance were worth $187,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in WBA. Norges Bank acquired a new stake in Walgreens Boots Alliance during the fourth quarter worth about $58,241,000. Two Sigma Advisers LP boosted its position in shares of Walgreens Boots Alliance by 186.3% in the fourth quarter. Two Sigma Advisers LP now owns 7,740,100 shares of the pharmacy operator’s stock worth $72,215,000 after buying an additional 5,036,300 shares during the period. Wealthquest Corp purchased a new stake in shares of Walgreens Boots Alliance in the first quarter worth about $38,457,000. Invesco Ltd. boosted its position in shares of Walgreens Boots Alliance by 8.8% in the fourth quarter. Invesco Ltd. now owns 32,572,567 shares of the pharmacy operator’s stock worth $303,902,000 after buying an additional 2,631,332 shares during the period. Finally, Two Sigma Investments LP boosted its position in shares of Walgreens Boots Alliance by 101.2% in the fourth quarter. Two Sigma Investments LP now owns 4,595,507 shares of the pharmacy operator’s stock worth $42,876,000 after buying an additional 2,311,806 shares during the period. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Walgreens Boots Alliance Price Performance

Shares of WBA opened at $11.45 on Friday. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $13.25. The company has a current ratio of 0.61, a quick ratio of 0.32 and a debt-to-equity ratio of 0.92. The firm has a market cap of $9.91 billion, a price-to-earnings ratio of -1.57, a PEG ratio of 1.35 and a beta of 0.78. The stock has a 50 day moving average of $11.21 and a 200-day moving average of $10.83.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.34 by $0.04. Walgreens Boots Alliance had a positive return on equity of 16.39% and a negative net margin of 4.07%. The firm had revenue of $38.99 billion for the quarter, compared to analysts’ expectations of $36.72 billion. During the same period last year, the business posted $0.63 earnings per share. The firm’s revenue for the quarter was up 7.2% on a year-over-year basis. As a group, analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Insider Buying and Selling at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, Chairman Stefano Pessina bought 832,258 shares of the stock in a transaction on Sunday, April 27th. The stock was purchased at an average price of $11.01 per share, for a total transaction of $9,163,160.58. Following the completion of the purchase, the chairman now directly owns 145,621,079 shares in the company, valued at approximately $1,603,288,079.79. This trade represents a 0.57% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 17.50% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on WBA shares. Wall Street Zen started coverage on Walgreens Boots Alliance in a research report on Wednesday, May 21st. They issued a “hold” rating for the company. UBS Group reaffirmed a “neutral” rating on shares of Walgreens Boots Alliance in a research report on Thursday. Deutsche Bank Aktiengesellschaft downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating and decreased their target price for the stock from $11.00 to $9.00 in a research report on Friday, February 28th. Finally, Morgan Stanley reaffirmed an “underweight” rating on shares of Walgreens Boots Alliance in a research report on Thursday. Four analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, Walgreens Boots Alliance currently has an average rating of “Hold” and a consensus price target of $10.59.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.